Available as global test only. Markers are CD304/CD73, CD45, CD19, CD34, CD38, CD10, CD22, CD58, CD66C/CD123, CD13/CD33, and CD20. Additional markers (CD13, CD14, CD16, CD45, and HLA-DR) are included for bone marrow samples to aid in evaluating the extent of hemodilution in bone marrow aspirates. This panel can detect MRD at the 0.01% level.
B-ALL MRD Flow Panel
- Flow Cytometry
- Epic Aura Integration
Specimen Requirements
Bone marrow aspirate: 2-3 mL EDTA preferred. Sodium heparin is acceptable.
Peripheral blood: 5-6 mL EDTA preferred. Sodium heparin is acceptable.
NY Clients: Please provide Date and Time of Collection.
Note: Lithium heparin or ACD (pale yellow/no gel separator) is not acceptable. Please provide recent CBC report.
Storage and Transportation
Specimens should be received at NeoGenomics within 72 hours from collection to assure sample integrity and acceptable cell viability. Note: New York State samples must be received within 48 hours from collection per NYS requirements. Refrigerate specimen. Do not freeze. Use cold pack for transport, making sure cold pack is not in direct contact with specimen.
CPT Code(s)*
Bone Marrow samples: 88184x1, 88185x13. Peripheral Blood samples: 88184x1, 88185x10. Add 88188x1 for global.
Turnaround time
24 Hours
Level of Service
- Global
Integrations
- Epic Aura
New York Approved: Yes
*The CPT codes provided with our test descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.
Biomarkers
Flow Cytometry
| Markers | |||||
|---|---|---|---|---|---|
| CD10 | CD13 | CD13/CD33 | CD14 | CD16 | CD19 |
| CD20 | CD22 | CD304/CD73 | CD34 | CD38 | CD45 |
| CD58 | CD66C/CD123 | HLA-DR | |||
Last Updated: June 17, 2026